BioPower Operations Corporation (BOPO)

BioPower Operations Income Statement

Financials in millions USD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2015
Period Ending	May 31, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019	Nov 30, 2015
Revenue	0.13	0.57	0.18	-	-	0.01
Revenue Growth (YoY)	-79.89%	226.69%	-	-	-	-
Gross Profit	0.13	0.57	0.18	-	-	0.01
Selling, General & Admin	5.3	1.16	0.46	-	-	1.88
Other Operating Expenses	-	-	-	-	-	0.08
Operating Expenses	5.98	1.16	0.46	-	-	1.97
Operating Income	-5.85	-0.59	-0.29	-	-	-1.96
Interest Expense	-0.31	-0.27	-0.16	-0.13	-0.13	-0.24
Other Non Operating Income (Expenses)	-0	0.07	-	-	-	-0.01
EBT Excluding Unusual Items	-6.17	-0.79	-0.44	-0.13	-0.13	-2.21
Gain (Loss) on Sale of Assets	-	-	-	-	-	-0
Pretax Income	-6.17	-0.79	-0.44	-0.13	-0.13	-2.21
Net Income	-6.17	-0.79	-0.44	-0.13	-0.13	-2.21
Net Income to Common	-6.17	-0.79	-0.44	-0.13	-0.13	-2.21
Shares Outstanding (Basic)	46	45	44	43	43	42
Shares Outstanding (Diluted)	46	45	44	43	43	42
Shares Change (YoY)	1.15%	3.16%	1.87%	-	3.32%	33.35%
EPS (Basic)	-0.14	-0.02	-0.01	-0.00	-0.00	-0.05
EPS (Diluted)	-0.14	-0.02	-0.01	-0.00	-0.00	-0.05
Free Cash Flow	0.13	0.31	-0.2	-	-	-0.3
Free Cash Flow Per Share	0.00	0.01	-0.01	-	-	-0.01
Gross Margin	100.00%	100.00%	100.00%	-	-	100.00%
Operating Margin	-4682.44%	-103.51%	-163.58%	-	-	-14570.72%
Profit Margin	-4934.01%	-138.63%	-252.19%	-	-	-16478.09%
Free Cash Flow Margin	102.99%	53.54%	-116.59%	-	-	-2201.84%
EBITDA	-	-	-	-	-	-1.95
D&A For EBITDA	-	-	-	-	-	0.01
EBIT	-5.85	-0.59	-0.29	-	-	-1.96
EBIT Margin	-	-103.51%	-163.58%	-	-	-
Revenue as Reported	0.13	0.57	0.18	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.